Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
MMWR Morb Mortal Wkly Rep ; 68(29): 642-646, 2019 Jul 26.
Article in English | MEDLINE | ID: mdl-31344023

ABSTRACT

The number of wild poliovirus (WPV) cases in Nigeria decreased from 1,122 in 2006 to six WPV type 1 (WPV1) in 2014 (1). During August 2014-July 2016, no WPV cases were detected; during August-September 2016, four cases were reported in Borno State. An insurgency in northeastern Nigeria had resulted in 468,800 children aged <5 years deprived of health services in Borno by 2016. Military activities in mid-2016 freed isolated families to travel to camps, where the four WPV1 cases were detected. Oral poliovirus vaccine (OPV) campaigns were intensified during August 2016-December 2017; since October 2016, no WPV has been detected (2). Vaccination activities in insurgent-held areas are conducted by security forces; however, 60,000 unvaccinated children remain in unreached settlements. Since 2018, circulating vaccine-derived poliovirus type 2 (cVDPV2) has emerged and spread from Nigeria to Niger and Cameroon; outbreak responses to date have not interrupted transmission. This report describes progress in Nigeria polio eradication activities during January 2018-May 2019 and updates the previous report (2). Interruption of cVDPV2 transmission in Nigeria will need increased efforts to improve campaign quality and include insurgent-held areas. Progress in surveillance and immunization activities will continue to be reviewed, potentially allowing certification of interruption of WPV transmission in Africa in 2020.


Subject(s)
Disease Eradication , Disease Outbreaks/prevention & control , Poliomyelitis/prevention & control , Population Surveillance , Adolescent , Child , Child, Preschool , Disease Outbreaks/statistics & numerical data , Humans , Immunization Programs , Infant , Nigeria/epidemiology , Poliomyelitis/epidemiology , Poliovirus/genetics , Poliovirus/isolation & purification , Poliovirus Vaccines/administration & dosage , Program Evaluation , Serogroup , Violence
SELECTION OF CITATIONS
SEARCH DETAIL
...